JP2019510482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510482A5 JP2019510482A5 JP2018544785A JP2018544785A JP2019510482A5 JP 2019510482 A5 JP2019510482 A5 JP 2019510482A5 JP 2018544785 A JP2018544785 A JP 2018544785A JP 2018544785 A JP2018544785 A JP 2018544785A JP 2019510482 A5 JP2019510482 A5 JP 2019510482A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- methods
- derived
- culture medium
- beta cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16157181 | 2016-02-24 | ||
| EP16157181.5 | 2016-02-24 | ||
| PCT/EP2017/054390 WO2017144695A1 (en) | 2016-02-24 | 2017-02-24 | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019510482A JP2019510482A (ja) | 2019-04-18 |
| JP2019510482A5 true JP2019510482A5 (enExample) | 2020-04-02 |
| JP7123802B2 JP7123802B2 (ja) | 2022-08-23 |
Family
ID=55588039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544785A Active JP7123802B2 (ja) | 2016-02-24 | 2017-02-24 | ヒト多能性幹細胞由来内分泌前駆細胞からの機能的ベータ細胞の産生 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11274280B2 (enExample) |
| EP (1) | EP3420073B1 (enExample) |
| JP (1) | JP7123802B2 (enExample) |
| CN (1) | CN108699515A (enExample) |
| ES (1) | ES2967942T3 (enExample) |
| MA (1) | MA45747A (enExample) |
| WO (1) | WO2017144695A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9388386B2 (en) | 2011-12-22 | 2016-07-12 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
| KR102580225B1 (ko) | 2013-06-11 | 2023-09-20 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | SC-β 세포 및 조성물 그리고 그 생성 방법 |
| JP6588969B2 (ja) | 2014-05-16 | 2019-10-09 | ヤンセン バイオテツク，インコーポレーテツド | 膵内分泌細胞内のｍａｆａ発現を強化するための小分子の使用 |
| WO2016100930A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Methods for generating stem cell-derived b cells and methods of use thereof |
| US11274280B2 (en) | 2016-02-24 | 2022-03-15 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
| EP4691479A3 (en) * | 2016-06-21 | 2026-04-15 | Janssen Biotech, Inc. | Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response |
| US20200199540A1 (en) * | 2017-09-11 | 2020-06-25 | Novo Nordisk A/S | Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells |
| CN118497104A (zh) | 2017-11-15 | 2024-08-16 | 沃泰克斯药物股份有限公司 | 胰岛细胞制备性组合物和使用方法 |
| EP3758719A4 (en) * | 2018-03-02 | 2021-12-08 | Vertex Pharmaceuticals Inc. | METHODS FOR IMPROVING THE DIFFERENTIATION OF STEM CELLS INTO BETA CELLS |
| EP3833365A4 (en) | 2018-08-10 | 2022-05-11 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
| CA3110932A1 (en) * | 2018-08-30 | 2020-03-05 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
| CN113728090B (zh) | 2019-04-08 | 2024-04-05 | 诺和诺德股份有限公司 | 从干细胞衍生的定形内胚层生成胰腺内胚层 |
| TW202115245A (zh) | 2019-06-27 | 2021-04-16 | 丹麥商諾佛 儂迪克股份有限公司 | 安全免疫隱形細胞 |
| CN114729323B (zh) | 2019-11-22 | 2024-09-17 | 诺和诺德股份有限公司 | 旋转聚集的神经微球及其应用 |
| US20240226179A1 (en) * | 2020-02-28 | 2024-07-11 | The Trustees Of The University Of Pennsylvania | Tissue culture media for survival and engraftment of human pancreatic islets |
| EP4114927A1 (en) | 2020-03-02 | 2023-01-11 | Novo Nordisk A/S | Use of pluripotent markers to detect contaminating residual undifferentiated pluripotent stem cells |
| CN116018150A (zh) | 2020-08-28 | 2023-04-25 | 诺和诺德股份有限公司 | 用于筛选干细胞衍生的β样细胞的体外群体的方法及其新型标志物 |
| WO2022129472A1 (en) | 2020-12-18 | 2022-06-23 | Novo Nordisk A/S | Safe immuno-stealth cells |
| WO2022136215A1 (en) | 2020-12-21 | 2022-06-30 | Novo Nordisk A/S | Safe immuno-stealth cells |
| CN113069440A (zh) * | 2021-04-08 | 2021-07-06 | 澳门大学 | 甲状腺素的新的应用、培养多能干细胞的方法和培养基 |
| EP4423254A4 (en) * | 2021-10-28 | 2026-01-14 | Memorial Sloan Kettering Cancer Center | COMPOSITIONS AND PROCESSES TO PROMOTE IN VITRO CELL MATURATION |
| WO2023118050A1 (en) | 2021-12-21 | 2023-06-29 | Novo Nordisk A/S | Use of novel markers to detect pluripotent stem cells |
| WO2024151541A1 (en) | 2023-01-09 | 2024-07-18 | Sana Biotechnology, Inc. | Type-1 diabetes autoimmune mouse |
| CN121604968A (zh) | 2023-05-22 | 2026-03-03 | 萨那生物科技公司 | 递送胰岛细胞的方法及相关方法 |
| WO2025093467A1 (en) | 2023-10-31 | 2025-05-08 | Novo Nordisk A/S | Methods for preventing unwanted cells arising during differentiation of human pluripotent stem cells |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010333839C1 (en) | 2009-12-23 | 2016-07-21 | Janssen Biotech Inc. | Differentiation of human embryonic stem cells |
| KR101986176B1 (ko) | 2010-05-12 | 2019-06-05 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| JP6312591B2 (ja) | 2011-06-21 | 2018-04-18 | ノヴォ ノルディスク アー／エス | 多能性幹細胞からの胚体内胚葉の効率的な誘導 |
| CN104411815B (zh) | 2012-04-30 | 2017-11-28 | 大学健康网络 | 用于从hPSC生成胰腺祖细胞和功能性β细胞的方法和组合物 |
| JP6470687B2 (ja) | 2012-09-03 | 2019-02-13 | ノヴォ ノルディスク アー／エス | 小分子を用いた多能性幹細胞からの膵臓内胚葉の作製 |
| WO2014048788A1 (en) | 2012-09-27 | 2014-04-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for producing a population of pancreatic beta-cells |
| RU2684215C2 (ru) | 2012-12-31 | 2019-04-04 | Янссен Байотек, Инк. | Способ получения панкреатических эндокринных клеток (варианты) и способ увеличения выхода бета-клеток |
| WO2014127219A1 (en) | 2013-02-14 | 2014-08-21 | The Cleveland Clinic Foundation | Methods for induction of cell fates from pluripotent cells |
| US10920192B2 (en) | 2013-04-23 | 2021-02-16 | Yeda Research And Development Co. Ltd. | Isolated naive pluripotent stem cells and methods of generating same |
| US9540613B2 (en) | 2013-04-29 | 2017-01-10 | Wisconsin Alumni Research Foundation | Methods for producing insulin-secreting beta cells from human pluripotent stem cells |
| KR102580225B1 (ko) | 2013-06-11 | 2023-09-20 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | SC-β 세포 및 조성물 그리고 그 생성 방법 |
| WO2015028614A1 (en) * | 2013-08-30 | 2015-03-05 | Novo Nordisk A/S | Generation of endocrine progenitor cells from human pluripotent stem cells using small molecules |
| US20150250824A1 (en) * | 2014-03-07 | 2015-09-10 | The Research Foundation For The State University Of New York | Methods and compositions for expansion of stem cells and other cells |
| JP6588969B2 (ja) | 2014-05-16 | 2019-10-09 | ヤンセン バイオテツク，インコーポレーテツド | 膵内分泌細胞内のｍａｆａ発現を強化するための小分子の使用 |
| US11274280B2 (en) | 2016-02-24 | 2022-03-15 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
| CA3110932A1 (en) | 2018-08-30 | 2020-03-05 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
-
2017
- 2017-02-24 US US16/078,763 patent/US11274280B2/en active Active
- 2017-02-24 JP JP2018544785A patent/JP7123802B2/ja active Active
- 2017-02-24 ES ES17709385T patent/ES2967942T3/es active Active
- 2017-02-24 MA MA045747A patent/MA45747A/fr unknown
- 2017-02-24 WO PCT/EP2017/054390 patent/WO2017144695A1/en not_active Ceased
- 2017-02-24 CN CN201780013255.3A patent/CN108699515A/zh active Pending
- 2017-02-24 EP EP17709385.3A patent/EP3420073B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019101200A (ru) | Генерация функциональных бета-клеток, полученных из человеческой плюрипотентной стволовой клетки, демонстрирующих реакцию в виде глюкозозависимого митохондриального дыхания и двухфазной секреции инсулина | |
| RU2012131400A (ru) | Дифференцировка человеческих эмбриональных стволовых клеток | |
| JP2019103521A5 (enExample) | ||
| ZA202309671B (en) | Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue | |
| AU2017254264A1 (en) | Method for producing retinal tissue | |
| JP2019518465A5 (enExample) | ||
| JP2017515507A5 (enExample) | ||
| NZ703888A (en) | Methods of generating natural killer cells | |
| MY177268A (en) | Medium system and method for ex vivo expansion of nk cells | |
| NZ709124A (en) | Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same | |
| WO2016168890A8 (en) | Generation of muscle-lineage cells from stem cells | |
| NZ759164A (en) | Liver organoid compositions and methods of making and using same | |
| EP2408903A4 (en) | PLURIPOTENTE AND MULTIPOTENTE CELL CULTURE ON MICROWAVES | |
| MX2020005907A (es) | Formulacion de medio libre de suero para cultivar celulas y metodos de uso de la misma. | |
| JP2016513972A5 (enExample) | ||
| PH12012501254A1 (en) | Differentiation of human embryonic stem cells | |
| AR094347A1 (es) | Cultivo de células madre embrionarias humanas en la interfase aire-líquido para la diferenciación en células endocrinas pancreáticas | |
| JP2015061520A5 (enExample) | ||
| RU2012105924A (ru) | Дифференцировка эмбриональных стволовых клеток человека | |
| ES2967942T3 (es) | Generación de células beta funcionales a partir de progenitoras endocrinas derivadas de células madre pluripotentes humanas | |
| JP2013536687A5 (enExample) | ||
| AR100446A1 (es) | Uso de moléculas pequeñas para mejorar la expresión de mafa en células endócrinas pancreáticas | |
| SE0850111L (sv) | Förfarande för differentiering av stamceller till celler av den endodermala och pankreatiska utvecklingslinjen | |
| BR112015022770A8 (pt) | meio e sistema de cultivo da célula livre de xenógeno, livre de albumina, forma concentrada, métodos de diferenciação de células-tronco pluripotentes humanas, para a produção de mesenquimoangioblastos e sistema definido de cultivo da célula para diferenciação hematoendotelial das células- tronco pluripotentes humanas | |
| BRPI0617378B8 (pt) | Uso de um inibidor de il-6 para produzir uma composição farmacêutica para suprimir dano a um ilhota transplantada depois do transplante de ilhota; e aperfeiçoar a viabilidade de uma ilhota em um transplante de ilhota |